ATE298742T1 - Zykloalkenylsulfonamidderivate - Google Patents

Zykloalkenylsulfonamidderivate

Info

Publication number
ATE298742T1
ATE298742T1 AT02733989T AT02733989T ATE298742T1 AT E298742 T1 ATE298742 T1 AT E298742T1 AT 02733989 T AT02733989 T AT 02733989T AT 02733989 T AT02733989 T AT 02733989T AT E298742 T1 ATE298742 T1 AT E298742T1
Authority
AT
Austria
Prior art keywords
cycloalkenylsulfonamide
derivatives
useful
psychiatric
patient
Prior art date
Application number
AT02733989T
Other languages
English (en)
Inventor
Buddy Eugene Cantrell
Dennis Michael Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE298742T1 publication Critical patent/ATE298742T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/08—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
AT02733989T 2001-05-30 2002-05-17 Zykloalkenylsulfonamidderivate ATE298742T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29442801P 2001-05-30 2001-05-30
PCT/US2002/011895 WO2002098847A1 (en) 2001-05-30 2002-05-17 Cycloalkenylsulfonamide derivatives

Publications (1)

Publication Number Publication Date
ATE298742T1 true ATE298742T1 (de) 2005-07-15

Family

ID=23133381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02733989T ATE298742T1 (de) 2001-05-30 2002-05-17 Zykloalkenylsulfonamidderivate

Country Status (7)

Country Link
US (1) US20040157817A1 (de)
EP (1) EP1395550B1 (de)
JP (1) JP2004529978A (de)
AT (1) ATE298742T1 (de)
CA (1) CA2447746A1 (de)
DE (1) DE60204882D1 (de)
WO (1) WO2002098847A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
RU2403242C2 (ru) * 2004-08-09 2010-11-10 Глэксо Груп Лимитед Соединения, которые усиливают рецептор глутамата, и их применение в медицине
DE602006003661D1 (de) 2005-06-06 2008-12-24 Lilly Co Eli Ampa-rezeptoren-verstärker
TW201431849A (zh) * 2005-06-06 2014-08-16 Lilly Co Eli Ａｍｐａ受體強化劑
JP5014334B2 (ja) * 2005-10-06 2012-08-29 イーライ リリー アンド カンパニー Ａｍｐａ受容体増強剤
GB0602560D0 (en) * 2006-02-08 2006-03-22 Glaxo Group Ltd Compounds
EP2356099A1 (de) * 2008-10-08 2011-08-17 Pfizer Inc. Tetrahydorfuranylsulfonamide zur verwendung als ampa-modulatoren bei der behandlung von zns-erkrankungen
JP2016521755A (ja) 2013-06-13 2016-07-25 ヴェロサイエンス，リミテッド・ライアビリティー・カンパニー 代謝障害を治療するための組成物および方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
WO2000006539A1 (en) * 1998-07-31 2000-02-10 Eli Lilly And Company Alkenyl sulphonamide derivatives
CA2338994A1 (en) * 1998-07-31 2000-02-10 Paul Leslie Ornstein Sulfonamide derivatives
US6358981B1 (en) * 1998-07-31 2002-03-19 Eli Lilly And Company Sulphonamide derivatives
ATE266400T1 (de) * 1998-07-31 2004-05-15 Lilly Co Eli Heterocyclyl sulphonamid derivate
US6639107B1 (en) * 1999-12-08 2003-10-28 Eli Lilly And Company Cyclopentyl sulfonamide derivatives

Also Published As

Publication number Publication date
WO2002098847A1 (en) 2002-12-12
CA2447746A1 (en) 2002-12-12
DE60204882D1 (de) 2005-08-04
JP2004529978A (ja) 2004-09-30
EP1395550B1 (de) 2005-06-29
EP1395550A1 (de) 2004-03-10
US20040157817A1 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
IS6922A (is) Heterófjölhringjaefnasambönd og notkun þeirra semmetabótrópísk mótlyf gegn glútamat viðtökum
YU63202A (sh) Derivati 2-okso-1-pirolidina, postupci za njihovo dobijanje i njihove upotrebe
MXPA06014721A (es) Derivados de alquinilo como moduladores de los receptores de glutamato metabotropico.
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
DE69820632D1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate
MXPA04006271A (es) Derivados de indolinona utiles como inhibidores de la proteina cinasa.
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
MY127686A (en) Monofluoroalkyl derivatives
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
DE60104697D1 (de) Sulfonamid-derivate
WO2002014294A3 (en) Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
WO2002014275A3 (en) Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
ATE298742T1 (de) Zykloalkenylsulfonamidderivate
DE50201565D1 (de) 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie
DK1399438T3 (da) Hidtil ukendte heteroarylderivater samt fremstilling og anvendelse heraf
DE502004007387D1 (de) Triazolverbindungen und ihre therapeutische verwendung
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
PL1603877T3 (pl) Nowe pochodne aminopirydyny jako antagoniści mGluR5
DK1368336T3 (da) Thiophensubstituerede aminderivater som GlyT-1-inhibitorer
MY136138A (en) Hexacyclic compounds
MXPA03011766A (es) Novedosos derivados de indol.
DE60203740D1 (de) Luminacine analoge und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties